|Bid||337.40 x 1800|
|Ask||199,999.98 x 800|
|Day's Range||333.93 - 341.18|
|52 Week Range||260.03 - 341.18|
|Beta (3Y Monthly)||0.91|
|PE Ratio (TTM)||27.46|
|Earnings Date||Jul 23, 2019 - Jul 29, 2019|
|Forward Dividend & Yield||1.20 (0.37%)|
|1y Target Est||359.00|
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Chemed Corp NYSE:CHEView full report here! Summary * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for CHE with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CHE. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $2.56 billion over the last one-month into ETFs that hold CHE are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is strong relative to the trend shown over the past year. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Shareholders of Chemed Corporation (CHE) today elected a slate of 10 directors at the Company’s 2019 annual shareholders’ meeting. Shareholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2019 and approved Chemed’s executive compensation. In addition, shareholders voted in favor of management’s recommendation to reject the shareholder proposal requesting a semi-annual report on the Company’s policies on political spending and political contributions made.
Chemed Corporation (CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 21, 2019, at approximately 11:00 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City. The audio webcast can be accessed by visiting the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours after the live presentation and will be accessible for 90 days.
Chemed Corporation (CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019, at 3:00 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today we'll look at Chemed Corporation (NYSE:CHE) and reflect on its potential as an investment. Spec...
On a per-share basis, the Cincinnati-based company said it had profit of $2.70. Earnings, adjusted for one-time gains and costs, came to $2.92 per share. The operator of the Roto-Rooter plumbing service ...
Chemed Corporation , which operates VITAS Healthcare Corporation , one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. […]
DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, rising expenses remain a dampener.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Kevin McNamara became the CEO of Chemed Corporation (NYSE:CHE) in 2001. This report will, first, examine the CEO c...
Chemed Corporation (CHE) today announced that it will release financial results for the first quarter ended March 31, 2019, on Monday, April 29, 2019, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Tuesday, April 30, 2019, to discuss the company's quarterly results and to provide an update on its business. The toll-free dial-in number for the conference call is 844-743-2500 for U.S. and Canadian participants and +1 661-378-9533 for international participants.
Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel
Chemed Corporation (NYSE:CHE), which is in the healthcare business, and is based in United States, saw a significant share price rise of over 20% in the past couple of monthsRead More...
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).